"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Descriptor ID |
D008103
|
| MeSH Number(s) |
C06.552.630
|
| Concept/Terms |
Liver Cirrhosis- Liver Cirrhosis
- Cirrhosis, Liver
- Cirrhoses, Liver
- Liver Cirrhoses
- Hepatic Cirrhosis
- Cirrhoses, Hepatic
- Cirrhosis, Hepatic
- Hepatic Cirrhoses
|
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".
This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 2 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 2 | 5 |
| 2004 | 6 | 3 | 9 |
| 2005 | 6 | 1 | 7 |
| 2006 | 4 | 2 | 6 |
| 2007 | 2 | 2 | 4 |
| 2008 | 5 | 2 | 7 |
| 2009 | 6 | 3 | 9 |
| 2010 | 9 | 3 | 12 |
| 2011 | 17 | 8 | 25 |
| 2012 | 13 | 3 | 16 |
| 2013 | 17 | 1 | 18 |
| 2014 | 15 | 2 | 17 |
| 2015 | 15 | 10 | 25 |
| 2016 | 21 | 6 | 27 |
| 2017 | 23 | 9 | 32 |
| 2018 | 22 | 11 | 33 |
| 2019 | 24 | 8 | 32 |
| 2020 | 25 | 18 | 43 |
| 2021 | 16 | 30 | 46 |
| 2022 | 5 | 39 | 44 |
| 2023 | 5 | 48 | 53 |
| 2024 | 33 | 14 | 47 |
| 2025 | 13 | 0 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.
-
The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis. Biomed Pharmacother. 2025 Sep; 190:118427.
-
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection. Metabolomics. 2025 Jul 01; 21(4):96.
-
Prevalence of fibrosis in hepatic explants and biopsies from individuals with urea cycle disorders. Mol Genet Metab. 2025 Aug; 145(4):109175.
-
Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosis. Hepatol Commun. 2025 Jul 01; 9(7).
-
Comparing the performance of 3 sarcopenia definitions for predicting adverse events prior to liver transplant. Hepatol Commun. 2025 Jun 01; 9(6).
-
Assessment of Liver Fibrosis Through Shear Wave Elastography in Pediatric Liver Transplant Recipients. Pediatr Transplant. 2025 May; 29(3):e70056.
-
Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study. Am J Gastroenterol. 2025 Apr 23; 120(8):1800-1808.
-
Clinical and pathophysiological characteristics of non-acute decompensation of cirrhosis. J Hepatol. 2025 Sep; 83(3):670-681.
-
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 05; 10(5):418-430.
-
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus Interferon. Aliment Pharmacol Ther. 2025 Apr; 61(7):1226-1237.